sd-rxRNAs for adoptive T-cell therapy (Phio Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesd-rxRNAs for adoptive T-cell therapy (Phio Pharmaceuticals)
Drug Alias Namesd-rxRNAs for adoptive T-cell therapy (RXi Pharmaceuticals)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhio Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhio Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A